Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1488-1491

  Hospers, Geke A P ^a   Calogero, Anna ^a   Van Waarde, Aren ^a   Doze, Petra ^a   Vaalburg, Willem ^a   Mulder, Nanno H ^a   De Vries, Erik F J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CANCER; DIAGNOSTIC VALUE; ENZYME ACTIVITY; GENE THERAPY; HERPES SIMPLEX; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; VIRUS CARCINOGENESIS;

ANIMALS; FEMALE; FLUORINE RADIOISOTOPES; GANCICLOVIR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INHIBITORY CONCENTRATION 50; NEOPLASMS, EXPERIMENTAL; RATS; RATS, NUDE; SIMPLEXVIRUS; THYMIDINE KINASE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR CELLS, CULTURED;

EID: 0034653735     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Singhal, S., and Kaiser, L. R. Cancer chemotherapy using suicide genes. Surg. Oncol. Clin. N. Am., 7: 505-536, 1998.
2. Blasberg, R. G., and Tjuvajev, J. G. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. Q. J. Nucl. Med., 43: 163-169, 1999.
3. Ram, Z., Culver, K. W., Oshiro, E. M., Violla, J. J., De Vroom, H. L., Otto, E., Chiang, Y., McGarrity, G. J., Muul, L. M., Katz, D., Blaese, R. M., and Oldfield, E. H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med., 3: 1354-1361, 1997.
4. Rosenberg, S. A., Blaese, R. M., Brenner, M. K., Deisseroth, A. B., Ledley, F. D., Lotze, M. T., Wilson, J. M., Nabel, G. J., Cornetta, K., Economous, J. S., Freeman, S. M., Riddell, S. R., Oldfield, E., Gansbacher, B., Dunbar, C., Walker, R. E., Schuening, F. G., Roth, J. A., Crystal, R. G., Welsh, M. J., Culver, K., Heslop, H. E., Simons, J., Wilmott, R. W., and Boucher, R. C. Human gene marker/therapy clinical protocols. Hum. Gene Ther., 8: 2301-2338, 1997.
5. Tjuvajev, J. G., Stockhammer, G., Desai, R., Uehara, H., Watanabe, K., Gansbacher, B., and Blasberg, R. G. Imaging the expression of transfected genes in vivo. Cancer Res., 55: 6126-6132, 1995.
6. Tjuvajev, J. G., Avril, N., Oku, T., Sasjima, T., Miyagawa, T., Joshi, R., Safer, M., Beattie, B., DiResta, G., Daghighian, F., Augensen, F., Koutcher, J., Zweit, J., Humm, J., Larson, S. M., Finn, R., and Blasberg R. Imaging of herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res., 58: 4333-4341, 1998.
7. Gambhir, S. S., Barrio, J. R., Phelps, M. E., Iyer, M., Namavari, M., Satyamuurthy, N., Wu, L., Green, L. A., Bauer, E., MacLaren, D. C., Nguyen, K., Berk, A. J., Cherry, S. R., and Herschman, H. R. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. USA, 96: 2333-2338, 1999.
8. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl. Med. Biol., 26: 371-376, 1999.
9. Alauddin, M. M., Conti, P. S., Mazza, S. M., Hamzeh, F. M., and Lever, J. R. A novel synthesis suitable for labeling the antiviral agenl 9-[(3-fluoro-1-hydroxy-2-propoxy)methyl] guanine (FHPG) with F-18 for in vivo imaging by positron emission tomography. In: 206th Meeting of the American Chemical Society, Chicago, IL, 1993.
10. Keller, P. M., Fyfe, J. A., and Beauchamp, L. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem. Pharmacol., 30: 3071-3077, 1981.
11. 18F]fluoro-1-hydroxy-2-propoxy)methyl}guanine. Bioorg. Med. Chem. Lett., 7: 1879-1882, 1997.
12. 18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl. Med. Biol., 25: 175-180, 1998.
13. 18F]fluoro-3-hydroxy-2-propoxy)methyl}guanine as radiopharmaceuticals for gene therapy. J. Label. Compd. Radiopharm., 42 (Suppl. I): S627-S629, 1999.
14. 18F]FHPG): a potential imaging agenl of viral infection and gene therapy using PET. Nucl. Med. Biol. 23: 787-792, 1996.
15. 18F]FHPG, 2): a promising agent for monitoring HSV-tk gene transfer to tumors. J. Label. Compd. Radiopharm., 42 (Suppl. I): S13-S15, 1999.
16. Cheng, Y-C., Dutschman, G., Fox, J. J., Walanabe, K. A., and Machida, H. Differential activity of potential antiviral nucleotide analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob. Agents Chemother., 20: 420-423, 1981.
17. Pentlow, K. S., Graham, M. C., Lambrecht, R. M., Daghighian, F., Bacharach, S. L., Bendriem, B., Finn, R. D., Jordan, K., Kalaigian, H., Karp, J. S., Robeson, R., and Larson, S. M. Quantitative imaging of iodine-124 with PET. J. Nucl. Med., 37: 1557-1562, 1996.
18. Barrio, J. R., Namavari. M., Srinvasan, A., Gambhir, S., Cherry, S., Herschman, H., Phelps, M. E., and Satyamurthy, N. Carbon-8 radiofluorination of purines: a general approach to probe design for gene therapy in humans. In: XIIth International Symposium on Radiopharmaceutical Chemistry, pp. 348. Uppsala, Sweden: , 1997.
19. 18F]fluoro-3-hydroxy-2-propoxy)methyl}guanine. J. Label. Compd. Radiopharm., 37: 193-195, 1995.
20. Bading, J. R., Alauddin, M. M., Fissekis, J. H., Kirkman, E., Raman R. K., and Conti, P. S. Pharmacokinetics of F-18 fluorohydroxypropoxymethylguanine (FHPG) in primates. J. Nucl. Med., 38 (Suppl.): 43P, 1997.